AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9624241 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer patients without microalbuminuria
Number of subjects: 102
Study 9624241 — intervention group
Group type: COMPARATOR
Intervention: Controls (benign lung disorders)
Number of subjects: 102
Study 7875148 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF, 5 micrograms/kg daily (intravenously or subcutaneously) for ten days
Number of subjects: 20
Study 7875148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3340659 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoranger
Number of subjects: 20
Study 3340659 — intervention group
Group type: COMPARATOR
Intervention: Standard goniometer
Number of subjects: 20
Study 3340659 — intervention group
Group type: EXPERIMENTAL
Intervention: Both instruments
Number of subjects: 20
Study 3340659 — intervention group
Group type: COMPARATOR
Intervention: Orthoranger vs. manual goniometer
Number of subjects: 20
Study 31391027 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Attention Bias Modification Training (ABMT)
Number of subjects: 120
Study 31391027 — intervention group
Group type: COMPARATOR
Intervention: Control Attention Bias Modification Training (ABMT)
Number of subjects: 120
Study 27943031 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in 2 Worlds (L2W)
Number of subjects: 107
Study 27943031 — intervention group
Group type: COMPARATOR
Intervention: kiR (control)
Number of subjects: 107
Study 25993051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to promote the adoption of sun-safety policies
Number of subjects: 98
Study 23361871 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan for 6 months
Number of subjects: 42
Study 23361871 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication for first 3 months, then bosentan for 6 months)
Number of subjects: 42
Study 21382132 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC50/250/MF100
Number of subjects: 36
Study 21382132 — intervention group
Group type: COMPARATOR
Intervention: SFC50/500
Number of subjects: 36
Study 19565135 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary program of inspiratory muscle training for at least 2 weeks using a device with a load corresponding to 40% of the maximum inspiratory pressure
Number of subjects: 30
Study 19565135 — intervention group
Group type: COMPARATOR
Intervention: General advice without inspiratory muscle training
Number of subjects: 30
Study 17894257 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment participants received a series of mailed materials and two educational calls over 6 months.
Number of subjects: 2024
Study 17894257 — intervention group
Group type: COMPARATOR
Intervention: Control group received a mailed pamphlet.
Number of subjects: 2024
Study 14988574 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (not specified in detail)
Number of subjects: 58
Study 14988574 — intervention group
Group type: COMPARATOR
Intervention: Current standards of care (control group, not specified in detail)
Number of subjects: 58
Study 12624706 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging on a treadmill for 30 min
Number of subjects: 20
Study 12624706 — intervention group
Group type: COMPARATOR
Intervention: Cycling on a bicycle ergometer for 30 min
Number of subjects: 20
Study 9849179 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased oral fluid intake
Number of subjects: 0
Study 9849179 — intervention group
Group type: EXPERIMENTAL
Intervention: High osmolarity liquid intake
Number of subjects: 0
Study 7852747 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor (85% n‐3 fatty acid concentrate)
Number of subjects: 43
Study 7852747 — intervention group
Group type: COMPARATOR
Intervention: corn oil (4 capsules of 1g/day)
Number of subjects: 43
Study 2767502 — intervention group
Group type: EXPERIMENTAL
Intervention: Early dinner (dinner at 6 pm)
Number of subjects: 23
Study 2767502 — intervention group
Group type: COMPARATOR
Intervention: Late dinner (dinner at 9 pm)
Number of subjects: 23
Study 965543 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training
Number of subjects: 18
Study 965543 — intervention group
Group type: COMPARATOR
Intervention: Nonsupervised training
Number of subjects: 18
Study 965543 — intervention group
Group type: COMPARATOR
Intervention: No training control
Number of subjects: 18
Study 30240132 — intervention group
Group type: COMPARATOR
Intervention: CSL112 2 g
Number of subjects: 32
Study 30240132 — intervention group
Group type: COMPARATOR
Intervention: CSL112 6 g
Number of subjects: 32
Study 28790038 — intervention group
Group type: EXPERIMENTAL
Intervention: ParticiPAte CP (participation focused therapy)
Number of subjects: 36
Study 28790038 — intervention group
Group type: COMPARATOR
Intervention: Waitlist usual care
Number of subjects: 36
Study 24995862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic piezoelectric device, Perio 100% setting, level 8 (P100)
Number of subjects: 30
Study 24995862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic piezoelectric device, Surg 50% setting, level 1 (S50)
Number of subjects: 30
Study 24995862 — intervention group
Group type: COMPARATOR
Intervention: Gracey curettes (CUR)
Number of subjects: 30
Study 22276690 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate placement of wide-diameter implants in fresh molar extraction sockets
Number of subjects: 24
Study 22276690 — intervention group
Group type: COMPARATOR
Intervention: Delayed placement of wide-diameter implants in healed sites
Number of subjects: 24
Study 22276690 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (immediate and delayed placement)
Number of subjects: 24
Study 22276690 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately placed implants
Number of subjects: 24
Study 22276690 — intervention group
Group type: COMPARATOR
Intervention: Delayed placed implants
Number of subjects: 24
Study 21498904 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention group (IG) receiving weekly sessions of group‐based multicomponent cognitive intervention.
Number of subjects: 39
Study 21498904 — intervention group
Group type: COMPARATOR
Intervention: Active control group (CG) receiving pencil‐paper exercises for self‐study.
Number of subjects: 39
Study 21498904 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention group (IG) for aMCI.
Number of subjects: 39
Study 21498904 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention group (IG) for AD.
Number of subjects: 39
Study 18574688 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM1 null genotype
Number of subjects: 413
Study 18574688 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygote mutants in GSTP1
Number of subjects: 413
Study 18574688 — intervention group
Group type: EXPERIMENTAL
Intervention: Three‐way combination of GSTP1 105AA/AG and null genotypes for both GSTM1 and GSTT1
Number of subjects: 413
Study 18574688 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of breast cancer
Number of subjects: 413
Study 18574688 — intervention group
Group type: COMPARATOR
Intervention: GSTT1 null genotype
Number of subjects: 413
Study 17194949 — intervention group
Group type: EXPERIMENTAL
Intervention: Preclinic appointment telephone contact (group A)
Number of subjects: 100
Study 17194949 — intervention group
Group type: COMPARATOR
Intervention: No preclinic appointment telephone contact (group B)
Number of subjects: 100
Study 15165653 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI)
Number of subjects: 601
Study 15165653 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 601
Study 11922398 — intervention group
Group type: EXPERIMENTAL
Intervention: Troxerutin 150 mg and carbazochrome 1.5 mg
Number of subjects: 30
Study 11922398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9517631 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet 90 mg/kg b.i.d. for 21 days
Number of subjects: 23
Study 9517631 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir 5 mg/kg b.i.d. for 21 days
Number of subjects: 23
Study 8299789 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-stimulated, hCG-timed IUI
Number of subjects: 56
Study 8299789 — intervention group
Group type: COMPARATOR
Intervention: LH-timed IUI
Number of subjects: 56
Study 2680583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg protriptyline
Number of subjects: 7
Study 2680583 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg protriptyline
Number of subjects: 7
Study 2680583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 786204 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine 300 mg daily
Number of subjects: 51
Study 786204 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 150 mg daily
Number of subjects: 51
Study 786204 — intervention group
Group type: EXPERIMENTAL
Intervention: Deluded depressives
Number of subjects: 51
Study 786204 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondeluded depressives
Number of subjects: 51
Study 31063575 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium (400 μg twice daily)
Number of subjects: 3630
Study 31063575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3630
Study 28776629 — intervention group
Group type: EXPERIMENTAL
Intervention: No valve cast
Number of subjects: 60
Study 28776629 — intervention group
Group type: EXPERIMENTAL
Intervention: Univalve cast
Number of subjects: 60
Study 28776629 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalve cast
Number of subjects: 60
Study 25128968 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring graft (HS)
Number of subjects: 150
Study 25128968 — intervention group
Group type: COMPARATOR
Intervention: Patellar tendon (BTB)
Number of subjects: 150
Study 23461008 — intervention group
Group type: EXPERIMENTAL
Intervention: mexidol (2-ethyl-6-methyl-3-oxypyridine succinate)
Number of subjects: 62
Study 21223352 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 46
Study 21223352 — intervention group
Group type: COMPARATOR
Intervention: Sponge toothette
Number of subjects: 46
Study 19918595 — intervention group
Group type: EXPERIMENTAL
Intervention: Local antibiotics (two groups with proven efficacy)
Number of subjects: 57
Study 19918595 — intervention group
Group type: COMPARATOR
Intervention: 3% hydrogen peroxide (H2O2)
Number of subjects: 57
Study 16500952 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon anaesthesia (XE)
Number of subjects: 44
Study 16500952 — intervention group
Group type: COMPARATOR
Intervention: Total i.v. anaesthesia (TIVA)
Number of subjects: 44
Study 17261876 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic intermittent positive airway pressure (BIPAP)
Number of subjects: 56
Study 17261876 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV)
Number of subjects: 56
Study 17261876 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 56
Study 12801946 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice (pH 3.0)
Number of subjects: 11
Study 12801946 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidified Ensure (pH 3.0)
Number of subjects: 11
Study 12801946 — intervention group
Group type: COMPARATOR
Intervention: Neutral Ensure (pH 7.0)
Number of subjects: 11
Study 10618679 — intervention group
Group type: EXPERIMENTAL
Intervention: M235T genotype
Number of subjects: 128
Study 10618679 — intervention group
Group type: EXPERIMENTAL
Intervention: G(-6)A genotype
Number of subjects: 128
Study 10618679 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement of genotypes
Number of subjects: 128
Study 7491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 2 (3.4% fiber, 15.6% lipid)
Number of subjects: 18
Study 7491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 1 (6.4% fiber, 13.1% lipid)
Number of subjects: 18
Study 7491889 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 3 (4.4% fiber, 14.5% lipid)
Number of subjects: 18
Study 7491889 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 18
Study 7491889 — intervention group
Group type: COMPARATOR
Intervention: Diet 2 vs Diet 1
Number of subjects: 18
Study 1788456 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 54
Study 1788456 — intervention group
Group type: EXPERIMENTAL
Intervention: Xipamide
Number of subjects: 54
Study 1788456 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 54
Study 7338581 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 0
Study 7338581 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 0
Study 28643063 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step nucleic acid (OSNA) analysis of lymph nodes identified by indocyanine green (ICG) fluorescence during surgery.
Number of subjects: 16
Study 28643063 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG fluorescence identification of lymph nodes.
Number of subjects: 16
Study 28643063 — intervention group
Group type: EXPERIMENTAL
Intervention: OSNA analysis of ICG-labelled nodes compared to final histological nodal stage.
Number of subjects: 16
Study 28643063 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional histology and OSNA assessment of fresh lymph nodes.
Number of subjects: 16
Study 27515481 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BRS) without postdilatation
Number of subjects: 215
Study 27515481 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BRS) with postdilatation
Number of subjects: 215
Study 27515481 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 215
Study 27515481 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BRS)
Number of subjects: 215
Study 24878273 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive unilateral laminectomy for bilateral decompression (ULBD)
Number of subjects: 54
Study 24878273 — intervention group
Group type: COMPARATOR
Intervention: Open laminectomy
Number of subjects: 54
Study 24305422 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel hydroxyphenoxy propionic acid, ellagic acid, yeast extract, and salicylic acid formulation applied twice daily
Number of subjects: 82
Study 24305422 — intervention group
Group type: COMPARATOR
Intervention: Standard prescription combination of 4% hydroquinone cream and 0.025% tretinoin cream applied nightly
Number of subjects: 82
Study 24305422 — intervention group
Group type: EXPERIMENTAL
Intervention: Both products (novel formulation and prescription combination)
Number of subjects: 82
Study 19404314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg
Number of subjects: 669
Study 19404314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 10 mg
Number of subjects: 669
Study 19404314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 20 mg
Number of subjects: 669
Study 19404314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 669
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon A (30 night EW)
Number of subjects: 121
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon A (DW)
Number of subjects: 121
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: Galyfilcon A (DW)
Number of subjects: 121
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon B (6 night EW)
Number of subjects: 121
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon B (DW)
Number of subjects: 121
Study 18172068 — intervention group
Group type: EXPERIMENTAL
Intervention: All lens wear (DW, EW)
Number of subjects: 121
Study 16139808 — intervention group
Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation (TMS)
Number of subjects: 68
Study 16139808 — intervention group
Group type: COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation
Number of subjects: 68
Study 14616671 — intervention group
Group type: EXPERIMENTAL
Intervention: High stimulation rate (1800 pps/channel)
Number of subjects: 11
Study 14616671 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate stimulation rate (800 pps/channel)
Number of subjects: 11
Study 14616671 — intervention group
Group type: COMPARATOR
Intervention: Low stimulation rate (400 pps/channel)
Number of subjects: 11
Study 11050258 — intervention group
Group type: EXPERIMENTAL
Intervention: Home support
Number of subjects: 184
Study 11050258 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital admission
Number of subjects: 184
Study 9020557 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine stimulation
Number of subjects: 0
Study 9020557 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 9020557 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneously secreted saliva during radiotherapy
Number of subjects: 0
Study 9020557 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine-treated patients during radiotherapy
Number of subjects: 0
Study 9020557 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no specific intervention mentioned)
Number of subjects: 0
Study 1544585 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose antihypertensive medication (chlorthalidone)
Number of subjects: 4736
Study 1544585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study 3933028 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (3-week pretreatment)
Number of subjects: 17
Study 3933028 — intervention group
Group type: COMPARATOR
Intervention: d-Amphetamine (20 mg)
Number of subjects: 17
Study 31895413 — intervention group
Group type: EXPERIMENTAL
Intervention: MaSuRCA assembly
Number of subjects: 1
Study 31895413 — intervention group
Group type: COMPARATOR
Intervention: Canu, SMARTdenovo, Flye, Marvel, and MaSuRCA assemblers
Number of subjects: 1
Study 30257476 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mental health promotion intervention
Number of subjects: 196
Study 27329542 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone solution 2%
Number of subjects: 715
Study 27329542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study 24766637 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group‐based upper limb intervention (ULI)
Number of subjects: 42
Study 24766637 — intervention group
Group type: EXPERIMENTAL
Intervention: Distributed individualized upper limb intervention (ULI)
Number of subjects: 42
Study 24766637 — intervention group
Group type: COMPARATOR
Intervention: Upper limb intervention (ULI)
Number of subjects: 42
Study 22435740 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1903 (R,R-19a)
Number of subjects: 0
Study 20204490 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms at the beginning of the year
Number of subjects: 113
Study 18549463 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.0 micro/kg/week plus RBV 8‐10 mg/kg/day for 24 weeks (group A)
Number of subjects: 53
Study 15852629 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion (6.17 +/- 0.98 mg x kg(‐1) x h(‐1)) after delivery
Number of subjects: 14
Study 15852629 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (1% until delivery)
Number of subjects: 14
Study 14592306 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral interface (Oracle)
Number of subjects: 38
Study 14592306 — intervention group
Group type: COMPARATOR
Intervention: Nasal masks
Number of subjects: 38
Study 10577755 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic lysis and lavage (ALL)
Number of subjects: 101
Study 10577755 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic anterolateral capsular release (AALCR)
Number of subjects: 101
Study 8568290 — intervention group
Group type: EXPERIMENTAL
Intervention: RRV‐TV (tetravalent rhesus-human rotavirus vaccine)
Number of subjects: 0
Study 8568290 — intervention group
Group type: EXPERIMENTAL
Intervention: RRV‐S1 (monovalent rhesus-human rotavirus vaccine)
Number of subjects: 0
Study 8568290 — intervention group
Group type: COMPARATOR
Intervention: Rotavirus vaccines (both RRV‐S1 and RRV‐TV)
Number of subjects: 0
Study 1658700 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (0.625 and 1.25 mg)
Number of subjects: 36
Study 1658700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7056949 — intervention group
Group type: EXPERIMENTAL
Intervention: RW-Cl (clustered doses of ragweed extract at 3-wk intervals)
Number of subjects: 44
Study 7056949 — intervention group
Group type: EXPERIMENTAL
Intervention: RW-Wk (weekly injections of single doses of ragweed extract)
Number of subjects: 44
Study 7056949 — intervention group
Group type: COMPARATOR
Intervention: Rinkel-method immunotherapy
Number of subjects: 44
Study 31502662 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar radiofrequency device with single microneedle, 3 treatments at 4-week intervals
Number of subjects: 63
Study 31502662 — intervention group
Group type: COMPARATOR
Intervention: Micro-needling and extraction (Control)
Number of subjects: 63
Study 30516102 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 1486
Study 30516102 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 1486
Study 30076270 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day donepezil
Number of subjects: 145
Study 30076270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 30076270 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day donepezil (in apolipoprotein ϵ 4 non-carriers)
Number of subjects: 145
Study 27381232 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Diabetes Prevention Program (DPP)
Number of subjects: 204
Study 27381232 — intervention group
Group type: COMPARATOR
Intervention: Standard Diabetes Prevention Program (DPP)
Number of subjects: 204
Study 25240072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy (HE) beverage (150 kcal)
Number of subjects: 44
Study 25240072 — intervention group
Group type: COMPARATOR
Intervention: No-energy (NE) beverage (0 kcal)
Number of subjects: 44
Study 23000523 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated Pulpal Pressure (SPP)
Number of subjects: 3
Study 23000523 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Water Exposure (DWE)
Number of subjects: 3